Plasmapheresis before thymectomy in myasthenia gravis: routine versus selective protocols

Area of Science:

• Neurology
• Immunology
• Surgical Management

Background:

• Thymectomy is a recognized treatment for myasthenia gravis (MG).
• Preoperative plasmapheresis (PMP) may enhance postoperative outcomes but carries risks.
• Selective PMP use aims to mitigate complications while optimizing results.

Purpose of the Study:

• To compare the effectiveness and safety of routine versus selective preoperative plasmapheresis (PMP) before thymectomy in MG patients.
• To evaluate the impact of PMP on postoperative outcomes and PMP-related complications.

Main Methods:

• Retrospective analysis of 164 MG patients undergoing thymectomy between 1998-2007.
• Comparison of two protocols: routine preoperative PMP (Group I) versus selective preoperative PMP (Group II).
• Group II patients were stratified by risk for PMP before thymectomy.

Main Results:

• Routine PMP (Group I, 74 patients) had a 25.7% complication rate.
• Selective PMP (Group II, 90 patients) had an 8.9% complication rate (35 received PMP, 55 did not).
• No significant differences were observed in postoperative mechanical ventilation duration, ICU stay, or hospital stay between groups.

Conclusions:

• Selective preoperative PMP in myasthenia gravis patients significantly reduces PMP-related complications.
• This selective strategy achieves comparable postoperative outcomes to routine PMP.
• Selective PMP is a safer approach for managing myasthenia gravis patients undergoing thymectomy.